Please assess the completion status of the following clinical trial:

Trial Title: Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults ≥ 18 years of age admitted to the intensive care unit~* New onset acute renal failure (ARF) or ARF superimposed on chronic kidney disease~* ARF will be defined by a sustained (over 24 hours) increase in serum creatinine \> 0.5 mg/dl from baseline~* Patients will be recruited for the study within 3-5 days following establishment of ARF~Exclusion Criteria:~* Institutionalized patient~* Previous kidney transplant~* Pregnancy~* Unable to obtain consent from subject or legally recognized representative~* ARF from urinary tract obstruction or a volume responsive pre-renal state.~* Liver Failure~* Recent cerebrovascular accident (CVA)~* Coagulopathy defined as: Platelets \< 50, PT \> 20, INR \> 2.0 if the patient requires the placement of an arterial or venous catheter; if the patient does not require the placement of an arterial or venous catheter for the study, coagulopathy will not be a basis for exclusion.~* Life expectancy \< 48 hours

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): supplement contains protein content of 1.4 g/kg/day
- 2 (Type: ACTIVE_COMPARATOR): supplement contains protein content of 2.0 g/kg/day

Based on this trial design, predict the completion outcome and termination type (if applicable).